Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Chardan Capital

EyePoint Pharmaceuticals Inc.
Start price
€9.92
07.05.24 / 50%
Target price
€25.98
07.05.25
Performance (%)
9.72%
Price
€10.88
17.05.24
Summary
This prediction is currently active. With a performance of 9.72%, the BUY prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 07.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w
EyePoint Pharmaceuticals Inc. -2.987%
iShares Core DAX® -0.383%
iShares Nasdaq 100 1.248%
iShares Nikkei 225® 0.525%
iShares S&P 500 0.640%

Comments by Chardan_Capital for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 9.72%
Target price 25.976
Change
Ends at 07.05.25

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Chardan Capital from $39.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat

Chardan Capital 
0
Report Share
07.05.24

Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.30
03.08.23
€20.11
03.08.24
0.31%
17.05.24

Chardan Capital 
03.08.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24

Chardan Capital 
03.03.23 50%